Company News in the Life Science Industry

»

Reset 

MiMedx Provides Update Regarding Timing of Restatement

MARIETTA, Ga., Dec. 12, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that it expects to file its annual report on Form 10-K for the years ended December... Read more ››

By: PR Newswire Association LLC. - 12 Dec 2019
Related companies:  MiMedx Group, Inc.

Statement from FDA Deputy Commissioner Frank Yiannas on new findings and current status of the romaine lettuce E. coli O157:H7 outbreak investigation

SILVER SPRING, Md., Dec. 12, 2019 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an update on our investigation of an outbreak of E. coli O157:H7 illnesses linked to Read more ››

By: PR Newswire Association LLC. - 12 Dec 2019
Related companies:  U.S. Food and Drug Administration

The Campus of Care Hosts Annual Fundraiser and Concert

TYLER, Texas, Dec. 12, 2019 /PRNewswire/ -- The Campus of Care Healthcare Corporation is hosting its annual fundraiser and concert at the Emmett J. Scott High School in Tyler, Texas on Saturday, December 14, 2019. Hors d'eurves will be served from 6:00 PM to 7:00 PM, and "An Evening in the Arts... Read more ››

By: PR Newswire Association LLC. - 12 Dec 2019

FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation

SILVER SPRING, Md., Dec. 12, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today granted accelerated approval to Vyondys 53 (golodirsen) injection to treat Duchenne muscular dystrophy (DMD) patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53... Read more ››

By: PR Newswire Association LLC. - 12 Dec 2019
Related companies:  U.S. Food and Drug Administration

Assembly Biosciences Announces Pricing of $125 Million Public Offering

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  Assembly Biosciences, Inc.

Equillium & Biocon Expand Exclusive Licensing Agreement for Itolizumab to Include Australia and New Zealand

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  Equillium, Inc.

Matinas BioPharma Announces Feasibility Evaluation with Third Large Biopharmaceutical Company for the Formulation of Compounds Utilizing LNC Delivery Platform

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  Matinas BioPharma Holdings Inc.

Trevena Presents Phase 1 Data on TRV250 for Acute Migraine at American College of Neuropsychopharmacology 2019 Annual Meeting

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  Trevena, Inc

Emerging Markets Report: First and Foremost

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  NeuroOne Medical Technologies Corporation

Aptinyx to Present at 38th Annual J.P. Morgan Healthcare Conference

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  Aptinyx Inc.

Intra-Cellular Therapies Highlights Lumateperone Presentations at the 58th Annual Meeting of the American College of Neuropsychopharmacology

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  Intra-Cellular Therapies, Inc.

Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  Marinus Pharmaceuticals, Inc.

Assertio Therapeutics Announces Sale of Gralise® for Total Transaction Value of $127.5 Million

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  Assertio Therapeutics, Inc

Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  Diffusion Pharmaceuticals Inc.

REPEAT - AgraFlora Organics Completes UK Home Office Controlled Drug Handling License Inspection

Read more ››
By: GlobenewsWire - 12 Dec 2019

Salarius Pharmaceuticals to Present Trial-in-Progress Poster at Epigenetics Symposium: 15 Years of Lysine Demethylases: From Discovery to the Clinic

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  Salarius Pharmaceuticals, LLC

Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  Momenta Pharmaceuticals, Inc.

aTyr Pharma Announces Positive Interim Safety Results from Ongoing Phase 1b/2a Clinical Trial of ATYR1923

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  Atyr Pharma, Inc. | Pharmsynthez

IBEX Reports Results for the First Quarter Ended October 31, 2019

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  IBEX Technologies Inc. | Infant Bacterial Therapeutics AB

Press release Swedish financier Mats Gabrielsson becomes major shareholder in Oncology Venture

Read more ››
By: GlobenewsWire - 12 Dec 2019
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies